Market Whales and Their Recent Bets on REGN Options
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors are showing a bearish sentiment towards Regeneron Pharmaceuticals (NASDAQ:REGN) through significant options activity. The options scanner at Benzinga highlighted 8 extraordinary options activities, with 50% of the sentiment being bearish. The stock is currently trading at $939.78, down by 2.34%, and analysts have mixed ratings with price targets ranging from $1050 to $1260.
October 23, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is experiencing significant bearish options activity, with 50% of the sentiment being bearish. The stock is currently down by 2.34% at $939.78. Analysts have mixed ratings with price targets ranging from $1050 to $1260.
The significant bearish sentiment from options traders suggests a negative outlook for REGN in the short term. The stock's current decline and mixed analyst ratings further support this bearish sentiment. The options activity indicates that major market players are expecting potential downside, which could impact the stock price negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100